High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy

Wong, Christopher C. Y., Ng, Austin C. C., Lau, Jerrett K., Chow, Vincent, Chen, Vivien, Ng, Arnold C. T., Yong, Andy S. C., Sindone, Andrew P., Marwick, Thomas H. and Kritharides, Leonard (2016) High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy. Thrombosis and Haemostasis, 115 6: 1191-1199. doi:10.1160/TH15-11-0869


Author Wong, Christopher C. Y.
Ng, Austin C. C.
Lau, Jerrett K.
Chow, Vincent
Chen, Vivien
Ng, Arnold C. T.
Yong, Andy S. C.
Sindone, Andrew P.
Marwick, Thomas H.
Kritharides, Leonard
Title High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy
Journal name Thrombosis and Haemostasis   Check publisher's open access policy
ISSN 0340-6245
Publication date 2016-06
Year available 2016
Sub-type Article (original research)
DOI 10.1160/TH15-11-0869
Open Access Status Not Open Access
Volume 115
Issue 6
Start page 1191
End page 1199
Total pages 9
Place of publication Stuttgart, Germany
Publisher Schattauer GmbH
Collection year 2017
Language eng
Abstract The prognostic significance of patients presenting with pulmonary embolism (PE) and elevated International Normalised Ratio (INR) not on anticoagulant therapy has not been described. We investigated whether these patients had higher mortality compared to patients with normal INR. A retrospective study of patients admitted to a tertiary hospital with acute PE from 2000 to 2012 was undertaken, with study outcomes tracked using a state-wide death registry. Patients were excluded if they were taking anticoagulants or had inadequate documentation of their INR and medication status. Of the 1,039 patients identified, 94 (9 %) had an elevated INR (> 1.2) in the absence of anticoagulant use. These patients had higher mortality at six months follow-up (26 % vs 6 %, p< 0.001) compared to controls (INR ≤ 1.2). An INR > 1.2 at diagnosis was an independent predictor of death at six months post-PE (hazard ratio [HR] 2.9, 95 % confidence interval [CI] 1.8–4.7, p< 0.001). The addition of INR to a multivariable model that included the simplified pulmonary embolism severity index (sPESI), chest pain, and serum sodium led to a significant net reclassification improvement estimated at 8.1 %. The final model’s C statistic increased significantly by 0.04 (95 % CI 0.01–0.08, p=0.03) to 0.83 compared to sPESI alone (0.79). In summary, patients presenting with acute PE and elevated INR while not on anticoagulant therapy appear to be at high risk of death. Future validation studies in independent cohorts will clarify if this novel finding can be usefully incorporated into clinical decision making in patients with acute PE.
Keyword Anticoagulant
International normalised ratio
Mortality
Prognosis
Pulmonary embolism
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
Admin Only - School of Medicine
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Sun, 03 Jul 2016, 00:18:36 EST by System User on behalf of Learning and Research Services (UQ Library)